Group 1 - The company Meihao Medical (301363.SZ) announced that several major shareholders plan to reduce their holdings by a total of up to 14,220,200 shares, which represents 2.4997% of the company's total share capital [1] - The shareholders involved include Shenzhen Meitai Lian Industrial Co., Ltd., Shenzhen Meichuang United Investment Partnership, Shenzhen Meichuang Yintai Industrial Partnership, and Shenzhen Meichuang Jinda Investment Partnership, all of which are significant shareholders of the company [1] - The planned reduction will occur within three months after the announcement, with up to 2,843,100 shares to be sold through centralized bidding and up to 11,377,100 shares through block trading [1] Group 2 - The company's executives, including Vice President Yan Jun'e, Vice President Huang Kai, Vice President Yan Bo, and Director Joel Chan, also plan to reduce their holdings by a total of up to 54,264 shares, which is 0.0095% of the total share capital [2] - The major shareholders mentioned are all associated with the company's actual controller, Mr. Xiong Xiaochuan, who holds 66.67% of Meitai Lian's equity [2] - The other investment partnerships mentioned were established as employee stock ownership platforms prior to the company's initial public offering, with Mr. Xiong serving as the executive partner [2]
美好医疗：实际控制人一致行动人拟合计减持不超过2.4997%股份